Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Integrum

11,08 SEK

+2,40 %

Mindre end 1K følgere

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
+2,40 %
+28,99 %
-73,66 %
-44,45 %
-38,68 %
-40,62 %
-70,15 %
-64,03 %
-44,39 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Læs mere
Markedsværdi
295,48 mio. SEK
Aktieomsætning
1,38 mio. SEK
Omsætning
91,1 mio.
EBIT %
-46,52 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
2.3
2026

Delårsrapport Q3'26

4.6
2026

Årsrapport '26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse2.12.2025, 20.27

Integrum AB: Integrum's rights issue oversubscribed

Integrum
Selskabsmeddelelse21.11.2025, 06.00

Integrum AB: Integrum publishes Interim Report for Q2 2025/26

Integrum
Pressemeddelelse19.11.2025, 15.01

Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation

Integrum

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse18.11.2025, 15.12

Integrum AB: The subscription period in Integrum's rights issue has begun

Integrum
Selskabsmeddelelse14.11.2025, 07.00

Integrum AB: Integrum publishes information document regarding rights issue

Integrum
Selskabsmeddelelse13.11.2025, 16.56

Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26

Integrum
Selskabsmeddelelse10.11.2025, 15.55

Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs

Integrum
Selskabsmeddelelse23.10.2025, 11.35

Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus

Integrum
Pressemeddelelse20.10.2025, 08.37

Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum

Integrum
Pressemeddelelse16.10.2025, 11.35

DNB Carnegie Access: Integrum: Withdrawing fair value

Integrum
Selskabsmeddelelse16.10.2025, 06.31

Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report

Integrum
Selskabsmeddelelse16.10.2025, 06.30

Integrum AB: Integrum provides operational update ahead of Q2 report

Integrum
Selskabsmeddelelse18.9.2025, 00.45

Integrum AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information

Integrum
Selskabsmeddelelse16.9.2025, 22.30

Integrum AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer

Integrum
Pressemeddelelse16.9.2025, 05.59

DNB Carnegie Access: Integrum: OsteoCentric offer fails to reach 90% threshold

Integrum
Pressemeddelelse4.9.2025, 14.23

Integrum AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly

Integrum
Pressemeddelelse2.9.2025, 08.33

Redeye: Integrum Q1 - Miss on sales

Integrum
Selskabsmeddelelse1.9.2025, 11.16

Integrum AB: Correction of Figures in Interim Report for the First Quarter 2025/26

Integrum
Pressemeddelelse1.9.2025, 06.39

DNB Carnegie Access: Integrum: Solid improvement continues – Q1(25/26) initial

Integrum
Selskabsmeddelelse1.9.2025, 05.15

Integrum AB: Stronger positioning paves the way for continued growth

Integrum
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.